Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease

Revision of the criteria for Alzheimer's disease: A symposium

(2011) Steven T. DeKosky et al.   Alzheimers & Dementia

Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment

(2011) Jennifer L. Bayer-Carter et al.   ARCHIVES OF NEUROLOGY

Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology

(2011) Anne M. Fagan   ARCHIVES OF NEUROLOGY

Pittsburgh Compound B-Negative Dementia—A Possibility of Misdiagnosis of Patients With Non-Alzheimer Disease-Type Dementia as Having AD

(2011) Hiroyuki Shimada et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

(2011) P. L. McClean et al.   JOURNAL OF NEUROSCIENCE

Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease

(2010) William T. Hu et al.   ACTA NEUROPATHOLOGICA

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

(2010) John Q. Trojanowski et al.   Alzheimers & Dementia

Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease

(2010) Lisa Mosconi et al.   Annals of the New York Academy of Sciences

Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E ε4 Allele

(2010) Jessica B. S. Langbaum et al.   ARCHIVES OF NEUROLOGY

Effects of Aerobic Exercise on Mild Cognitive Impairment

(2010) Laura D. Baker et al.   ARCHIVES OF NEUROLOGY

Role of biochemical Alzheimer’s disease biomarkers as end points in clinical trials

(2010) Eric Siemers et al.   Biomarkers in Medicine

Biomarkers in Alzheimer’s disease: past, present and future

(2010) Katarzyna Gustaw-Rothenberg et al.   Biomarkers in Medicine

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

(2010) Niklas Mattsson et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

The Development of New Therapeutics for Alzheimer's Disease

(2010) M D Carter et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2010) Michael Gold et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents

(2010) R.K. Kaundal et al.   DRUG NEWS & PERSPECTIVES

Bapineuzumab

(2010) Geoffrey A Kerchner et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Imaging and biomarkers for Alzheimer's disease

(2010) Charlotte L. Allan et al.   MATURITAS

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

(2010) Piet Eikelenboom et al.   Neurodegenerative Diseases

Neuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease

(2010) Inelia Morales et al.   NEUROIMMUNOMODULATION

Classification and basic pathology of Alzheimer disease

(2009) Charles Duyckaerts et al.   ACTA NEUROPATHOLOGICA

Mechanisms of tau-induced neurodegeneration

(2009) Khalid Iqbal et al.   ACTA NEUROPATHOLOGICA

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway

(2009) Jian-hui Liu et al.   ACTA PHARMACOLOGICA SINICA

CSF Biomarkers

(2009) Niklas Mattsson et al.   Annals of the New York Academy of Sciences

Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease

(2009) Zivar Salehi et al.   BIOFACTORS

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

(2009) Alex E. Roher et al.   BIOMARKERS

Value of Combining Activated Brain FDG-PET and Cardiac MIBG for the Differential Diagnosis of Dementia

(2009) Sergio L. Schmidt et al.   CLINICAL NUCLEAR MEDICINE

Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle

(2009) Vitaly Vasilevko et al.   CNS & Neurological Disorders-Drug Targets

Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice

(2009) Donna Wilcock et al.   CNS & Neurological Disorders-Drug Targets

Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum

(2009) Philine Schneider et al.   CNS Neuroscience & Therapeutics

The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease

(2009) S. Freude et al.   Current Alzheimer Research

Increase in the Oxidized/Total Coenzyme Q-10 Ratio in the Cerebrospinal Fluid of Alzheimer’s Disease Patients

(2009) Chiaki Isobe et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

MCI-plus: leichte kognitive Beeinträchtigung mit rascher Progredienz

(2009) H Förstl et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Monitoring the amyloid beta-peptide in vivo – caveat emptor

(2009) Paul W. Thompson et al.   DRUG DISCOVERY TODAY

Biomarkers for Alzheimer's disease

(2009) E.K.J. Pauwels et al.   DRUG NEWS & PERSPECTIVES

Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study

(2009) Silvia Morbelli et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

(2009) Lisa Mosconi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease

(2009) Paula L. McClean et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Protein kinase C as a peripheral biomarker for Alzheimer’s disease

(2009) Jean de Barry et al.   EXPERIMENTAL GERONTOLOGY

Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice

(2009) Michele D’Amico et al.   EXPERIMENTAL GERONTOLOGY

Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

(2009) Diane P Hanger et al.   Expert Review of Neurotherapeutics

Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease

(2009) Pasquale F Finelli   JOURNAL OF NEURO-OPHTHALMOLOGY

The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

(2009) John Hardy   JOURNAL OF NEUROCHEMISTRY

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

(2009) Chiaki Isobe et al.   JOURNAL OF NEUROLOGY

The 18F-FDG PET Cingulate Island Sign and Comparison to 123I- -CIT SPECT for Diagnosis of Dementia with Lewy Bodies

(2009) S. M. Lim et al.   JOURNAL OF NUCLEAR MEDICINE

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

(2009) Y. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer’s disease

(2008) M. A. Korolainen et al.   ACTA NEUROLOGICA SCANDINAVICA

Correlating Cerebral Hypometabolism With Future Memory Decline in Subsequent Converters to Amnestic Pre–Mild Cognitive Impairment

(2008) Richard J. Caselli et al.   ARCHIVES OF NEUROLOGY

(Pre)diabetes, brain aging, and cognition

(2008) Jarbas S. Roriz-Filho et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications

(2008) Karen Neumann et al.   Current Alzheimer Research

The ubiquitin-proteasome system in Alzheimer's disease

(2008) Salvatore Oddo   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview

(2008) Sonia Correia et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Glucagon-like Peptide-1 (GLP-1) Diminishes Neuronal Degeneration and Death Caused by NGF Deprivation by Suppressing Bim Induction

(2008) Subhas C. Biswas et al.   NEUROCHEMICAL RESEARCH

Biochemical markers in persons with preclinical familial Alzheimer disease

(2008) J. M. Ringman et al.   NEUROLOGY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia